Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP Dispute Resolution Concept Paper From FDA Expected In February

Executive Summary

FDA plans to release a concept paper in late February on technical dispute resolution as one update on its initiative to adapt risk assessment principles into good manufacturing practices for drugs and biologics

You may also be interested in...



GMP Dispute Resolution Pilot May Build In Delay Before Form 483 Is Issued

FDA's GMP dispute resolution pilot could allow drug inspectors a "short post-inspection delay" prior to issuing a Form 483 manufacturing report

GMP Dispute Resolution Pilot May Build In Delay Before Form 483 Is Issued

FDA's GMP dispute resolution pilot could allow drug inspectors a "short post-inspection delay" prior to issuing a Form 483 manufacturing report

FDA Manufacturing Subcmte. Should Track Industry/Agency Disputes – PhRMA

FDA's Pharmaceutical Science Advisory Committee's Manufacturing Subcommittee should track disputes between industry and the agency to identify areas in need of standards development, the Pharmaceutical Researchers & Manufacturers of America said

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel